Multiple system atrophy (MSA) is a rare and progressive neurodegenerative disorder that affects the autonomic nervous system, motor function, and balance. It manifests through a combination of parkinsonism, autonomic dysfunction, and cerebellar ataxia, making it distinct from Parkinson’s disease despite overlapping symptoms. Unlike Parkinson’s, MSA progresses rapidly, and available treatments focus mainly on symptom relief rather than addressing the root causes of the disease, leaving significant unmet medical needs.
As per DelveInsight’s analysis, approximately 70,000 people across the seven major markets (the United States, Germany, France, Italy, Spain, th...
